Lewy Body Dementia Clinical Trials

Dementia With Lewy Bodies (DLB) can make you feel like your wires are crossed

What is Lewy Body Dementia?

Dementia with Lewy bodies (DLB) is a type of dementia that shares symptoms with both Alzheimer’s disease and Parkinson’s disease. Find out more about Lewy Body, including the symptoms and risk factors, here.

New Lewy Body Dementia Clinical Trials

Our team of Brain and Mind Experts are providing volunteers with Lewy Body Disease, the opportunity to take part in international clinical trials to evaluate potential new treatments, designed to slow the progression of Lewy Body Disease and the symptoms.

We are looking for volunteers with the following traits:

• Aged 50 – 85 years old.
• Already have a diagnosis or suspected diagnosis of Lewy body.
• Those who have experienced hallucinations from their disease.

Taking part in a clinical trial for Lewy body Disease gives individuals, with a suspected diagnosis, the chance to confirm accurately if this is indeed the cause of their symptoms and if so, access these new medicines under evaluation. If you or your loved one fits these criteria then please sign up below.

Why take part in a Clinical Trial for Lewy Body Disease?

• Volunteers participating in clinical studies at Re:Cognition Health Centres receive world-class health care including comprehensive health screens, MRI scans and PET scans and regular monitoring by the highly-skilled team of cognitive experts, at no cost.
• Taking part in a clinical trial for Lewy Body Disease also provides the opportunity to be part of much-needed research to find medications, and ultimately a cure for Lewy Body, for current and future generations.
• Clinical trial participants also receive a contribution to travel costs to appointments and refreshments are provided.

We’re committed to finding new treatments for Lewy Body Disease. The more people taking part in clinical trials, the more likely we are to be able to do so.

Use the form below to register your interest in one of our clinical trials.

We will get in touch shortly with more information. There are also FAQs answered below the form.

Lewy Body Clinical Trial Frequently Asked Questions:

What Is Involved in this Study?

If you qualify and agree to be in this study, you will visit the study site for medical tests and assessments approximately 10 times for up to 22 weeks. Most visits will last from one to three hours, and two visits will last longer, potentially four to six hours.

You will be randomly placed into one of two treatment groups. One group will receive the study drug, and the other group will receive a placebo. The placebo looks like the study drug, but contains no active ingredient. The study drug (or the placebo) is a capsule you will take once a day, every morning, with or without food. Neither you nor the study staff will know which group you are in.

Participation is completely free and you are free to stop you participation at any point should you wish.

 What Is the Study Drug?

The study drug is thought to cause an increase in levels of a brain chemical known as cyclic guanosine monophosphate (cGMP). cGMP is a substance involved in how cells communicate with the brain, and increasing cGMP levels in the brain may improve cognitive function.

If you decide to take part, you will sign an informed consent form stating that the study details have been explained to you. However, this is not a contract and you may withdraw from the study for any reason, at any time.

You will be expected to follow the study staff’s instructions, take the study drug as directed, and keep your scheduled appointments.

Who Is Eligible to Participate?

Patients may qualify for this study if they:

• Are age 50-85
• Have probable DLB

Patients enrolled in this study must have a caregiver, friend, or family member who can provide information about the patient throughout the study. This person will attend all study visits with the subject. We will be happy to give you more information on the study criteria over the phone.

Will I Be Paid to Participate in this Study?

No; however, reasonable travel expenses for attending the study visits may be reimbursed.

The study drug and all study-related care will be provided to you at no cost.